Fractyl Health, Inc. Common Stock

GUTS XNAS • SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

120M

Short interest (Jul 15)

1.6%

Net Short (Jul 27 ): 0.1%

Borrow Fee

0.76%

↓ 7.4%

Available Shares

↓ 10.6%

Price Chart

Company Overview

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Company Info

Exchange: NASDAQ

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

CIK: 0001572616

Asset Type: CS

Market Data

Market Cap: $122,635,648

Employees: 73

Status: Active

Short Interest

Current Borrow Fee 0.76%

Range: 0.76% - 0.76%

Available Shares 8M

Range: 7.7M - 8.3M

Recent Changes

Fee Change: ↑ 1.5%

Available Change: ↓ 13.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime